A detailed history of Northcape Wealth Management, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Northcape Wealth Management, LLC holds 9,694 shares of BDX stock, worth $2.21 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares
9,694
Previous 9,555 1.45%
Holding current value
$2.21 Million
Previous $2.23 Million 4.66%
% of portfolio
0.77%
Previous 0.81%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$221.47 - $242.41 $30,784 - $33,694
139 Added 1.45%
9,694 $2.34 Million
Q2 2024

Jul 25, 2024

BUY
$225.07 - $246.17 $2,925 - $3,200
13 Added 0.14%
9,555 $2.23 Million
Q1 2024

Apr 30, 2024

SELL
$233.45 - $247.73 $70,968 - $75,309
-304 Reduced 3.09%
9,542 $2.36 Million
Q4 2023

Feb 05, 2024

SELL
$232.24 - $267.23 $10,218 - $11,758
-44 Reduced 0.44%
9,846 $2.4 Million
Q3 2023

Nov 06, 2023

BUY
$254.9 - $283.59 $78,254 - $87,062
307 Added 3.2%
9,890 $2.56 Million
Q2 2023

Aug 07, 2023

BUY
$238.39 - $265.32 $20,024 - $22,286
84 Added 0.88%
9,583 $2.53 Million
Q1 2023

May 15, 2023

BUY
$229.71 - $259.35 $169,525 - $191,400
738 Added 8.42%
9,499 $2.35 Million
Q4 2022

Feb 07, 2023

SELL
$218.29 - $256.91 $355,157 - $417,992
-1,627 Reduced 15.66%
8,761 $2.23 Million
Q3 2022

Nov 08, 2022

SELL
$51.03 - $264.23 $8,624 - $44,654
-169 Reduced 1.6%
10,388 $2.32 Million
Q2 2022

Aug 09, 2022

SELL
$234.74 - $275.42 $9,859 - $11,567
-42 Reduced 0.4%
10,557 $2.6 Million
Q1 2022

Apr 18, 2022

BUY
$243.64 - $270.48 $48,484 - $53,825
199 Added 1.91%
10,599 $2.82 Million
Q4 2021

Feb 09, 2022

BUY
$230.08 - $250.94 $2.39 Million - $2.61 Million
10,400 New
10,400 $2.62 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Northcape Wealth Management, LLC Portfolio

Follow Northcape Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northcape Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Northcape Wealth Management, LLC with notifications on news.